Adjuvant
US9056094B2 · kind B2 · utility
0Cited by
4References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 31, 2008 |
| Grant date | Jun 16, 2015 |
| Priority date | — |
| Expiry date | Oct 20, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/55516
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a vaccine adjuvant composition which is used in combination with an allergen vaccine, infection vaccine or tumor vaccine. The present invention specifically provides a vaccine adjuvant composition comprising hemozoin or β-hematin and being used in combination with an allergen vaccine, infection vaccine or tumor vaccine, and a vaccine composition comprising the vaccine adjuvant composition and an allergen vaccine, infection vaccine or tumor vaccine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.